RajSinghMD

Assistant Professor of Radiation Oncology at The Ohio State University Comprehensive Cancer Center / The James Cancer Hospital and Solove Research Institute

Join to view full profile

Dr. Singh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Singh's full profile

Already have an account?

Office
460 W 10th Ave
Fl 2
Columbus, OH 43210
Phone+1 614-293-8415

Fax+1 614-293-4044

Summary

Raj Singh, M.D., is an Assistant Professor of Radiation Oncology and board-certified clinical radiation oncologist at The Ohio State University Comprehensive Cancer Center and The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, with a clinical focus in central nervous system, thoracic, and pediatric malignancies (both primary and metastatic).

His undergraduate studies were completed at Duke University, where he graduated cum laude with a Bachelor's of Science in Economics with Distinction. He received his M.D. from Marshall University Joan C. Edwards School of Medicine in Huntington, WV, and completed his Transitional Year Internship at Mather Hospital (Northwell Health System) in Port Jefferson, NY. He completed his residency in Radiation Oncology at Virginia Commonwealth University Health System in Richmond, VA, and was named Chief Resident Physician his final year.

He has research interests in stereotactic ablative radiation therapy (SABR) and stereotactic radiosurgery (SRS) for oligometastatic disease and optimization of dose/fractionation schedule based on primary histology as well as patient selection, particularly in the pediatric population, and SRS for other intracranial applications.

He has published his work in JAMA Oncol, Int J Radiat Oncol Biol Phys, Radiother Oncol, Neurosurgery, J Neurosurg, J Neurooncol, Neuro-Oncol Adv, and Am J Clin Oncol on topics such as SRS for brain metastases and spinal metastases, SABR for various extracranial metastases, SRS for trigeminal neuralgia, dural arteriovenous fistulas, and recurrent brain metastases, and dose escalation for glioblastoma.

Local Control and Survival Outcomes After Stereotactic Radiosurgery for Brain Me

Local Control and Survival Outcomes After Stereotactic Radiosurgery for Brain Metastases From Gastrointestinal Primaries

CURiE Conversations: SABR for Adolescent and Young Adult Malignancies

In this episode of the ACRO podcast CURiE edition, CURiE editor Dr. Jessica Schuster speaks with author Dr. Raj Singh about his published article, "Stereotactic

Dr Singh on Unmet Medical Needs in Lung Cancer Treatment

Raj Singh, MD, discusses unmet medical needs in the treatment of patients with lung cancer.

Dr Singh on the Utility of Radiation Therapy in Lung Cancer

Raj Singh, MD, discusses radiation therapy in patients with lung cancer, highlighting the evolution of treatment within this landscape.

Dr Singh on Treating Lung Cancer CNS Metastasis Management Strategies

Raj Singh, MD, discusses treating patients with lung cancer with CNS metastases.

Raj Singh, MD | Radiation Oncology Specialist at the OSUCCC - James

Raj Singh, MD, is a Radiation Oncology Specialist, specializing in at the OSUCCC - James. Learn more.

Education & Training

Virginia Commonwealth University Health SystemResidency, Radiation Oncology, 2019 - 2023
Zucker School of Medicine at Hofstra/Northwell at Mather HospitalInternship, Transitional Year, 2018 - 2019
Marshall University Joan C. Edwards School of MedicineClass of 2018, M.D.
Duke UniversityBS, Economics, Cum Laude, Graduation with Distinction, 2010 - 2014

Certifications & Licensure

OH State Medical License 2023 - 2027
VA State Medical License 2019 - 2023

Publications & Presentations

PubMed

Impact of instrumentation material on local recurrence: a case-matched series using carbon fiber-PEEK vs. titanium.
Jacob Ward, Mark Damante, Seth Wilson, Vicente Coelho, Dominic Franceschelli
Journal of Neuro-Oncology. 2024-10-04
Hypofractionated Stereotactic Radiosurgery in the Management of Brain Metastases.
Eric J Lehrer, William G Breen, Raj Singh, Joshua D Palmer, Paul D Brown
Neurosurgery. 2024-08-01
Stereotactic Ablative Radiation Therapy (SABR) for Adolescent and Young Adult Malignancies.
Raj Singh, Sophia Bishop, Jan Jenkins, Joanne Davis, Rituraj Upadhyay
Cureus. 2024-08-01

Journal Articles

Clinical outcomes following stereotactic body radiation therapy (SBRT) for non-resectable pancreatic adenocarcinoma
Singh R, Ansinelli H, Sharma S, J Radiat Oncol, 9/1/2017
Promoting Reproductive Health Using Telemedicine: A Prospective Study Among Rural Appalachian High School Teens.
Singh R, Harsh M, Mullins K, Dunlap B, Yoost J, Marshall Journal of Medicine, 4/28/2017
Salvage Stereotactic Radiotherapy for Recurrent Glioblastoma Multiforme: Clinical Outcomes from a Multi-Institutional Registry.
Singh R, Sharma S, W V Med J OA, 4/3/2017
A Monte Carlo Simulation of Prostate Cancer Finds Significantly Higher Costs Adjusted for Quality Adjusted Life Years following no PSA Screening as compared to Routine...
Singh R, Heisey H, Gress T, Jensen J, W V Med J OA, 8/4/2016
Neurocognitive Dysfunction in Brain Tumor Patients following Radiation Therapy: A Review of Biological Hypotheses, Current Treatment Outcomes, and Novel Therapeutic S...
Singh R, Marshall Journal of Medicine, 1/25/2016
Has Tort Reform Been Effective in Abating the Medical Malpractice Crisis? An Empirical Analysis from 1991-2012
Singh R, Solanki J, Duke Journal of Economics, 4/16/2014
Join now to see all

Abstracts/Posters

Stereotactic Body Radiation Therapy (SBRT) for Metastatic Renal Cell Carcinoma: A Preliminary Retrospective Multi-Institutional Analysis
Singh R, Jenkins J, Davis JN, Sharma S, American Society of Radiation Oncology (ASTRO) Annual Meeting, Chicago, IL, 9/16/2019
Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Small-Cell Lung Carcinoma: A Preliminary Analysis from the RSSearch Patient Registry
Singh R, Ansinelli H, Jenkins J, Davis J, Vargo JA, Sharma S, The Radiosurgery Society SRS/SBRT 2019 Annual Scientific Meeting, San Diego, CA, 3/21/2019
Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy for Vestibular Schwannomas: A Comparison of Clinical Outcomes from the RSSearch Patient Regi...
Singh R, Ansinelli H, Jenkins J, Davis J, Sharma S, Vargo JA, The Radiosurgery Society SRS/SBRT 2019 Annual Scientific Meeting, San Diego, CA, 3/21/2019
Hyponatremic Encephalopathy in a Lactating Female: A Case Report on the Possible Antidiuretic Effects of Oxytocin
Purvi P, Bukkuri S, Singh R, Gunjupali P, Tofano M, AMA Research Symposium, National Harbor, MD, 11/9/2018
Salvage Stereotactic Body Radiation Therapy (SBRT) For Locally-Recurrent Previously Irradiated Head and Neck Squamous Cell Carcinoma: What Is The Appropriate Dose?
Singh R, Ansinelli H, Sharma D, Jenkins J, Vargo JA, Sharma S, American College of Radiation Oncology (ACRO) 2018 Summit, Fort Lauderdale, FL, 2/3/2018
A Retrospective Evaluation of the Effectiveness of Lower Doses of filgrastim in Achieving an Adequate Neutrophil Response in Cancer Patients
Singh R, Heisey H, Elsayed A, Tirona T, MUSOM 2017 Annual Research Day, Huntington, WV, 3/24/2017
A Hydrogel Spacer Results in Minimal GI Toxicity in the Setting of Comorbid Crohn's disease following Prostate Cancer Radiotherapy
Singh R, Jackson P, Sharma S, American College of Radiation Oncology (ACRO) 2017 Annual Meeting, Orlando, FL, 3/11/2017
Treatment Outcomes for Trigeminal Neuralgia Following Stereotactic Radiosurgery
Singh R, Sharma S, Davis J, The RSS SRS/SBRT 2016 Scientific Meeting, Orlando, FL, 6/16/2016
Salvage Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy for Recurrent Glioblastoma Multiforme
Singh R, Sharma S, Davis J, The RSS SRS/SBRT 2016 Scientific Meeting, Orlando, FL, 6/16/2016
Evaluating the Implications of Changes in PSA-Screening Guidelines on Prostate Cancer-Related Mortality, Utility, and Cost: A Decision Analysis Approach
Singh R, Heisey H, Gress T, Jensen J, MUSOM 2016 Annual Research Day, Huntington, WV, 3/11/2016
Pre-Clinical Evaluation of BMS-754807, an IGF-1R Inhibitor, in a Genetically Engineered DIPG Mouse Model
Singh R, Schroeder KM, Becher OJ, AACR 2013 Undergraduate Student Caucus, Washington, D.C., 4/2013
Join now to see all

Press Mentions

CURiE Conversations: SABR for Adolescent and Young Adult MalignanciesSeptember 9th, 2024
Dr Singh on Treating Lung Cancer CNS Metastasis Management StrategiesMarch 28th, 2024
Dr Singh on the Utility of Radiation Therapy in Lung CancerMarch 14th, 2024
Join now to see all